JP2017521060A5 - - Google Patents

Download PDF

Info

Publication number
JP2017521060A5
JP2017521060A5 JP2016573923A JP2016573923A JP2017521060A5 JP 2017521060 A5 JP2017521060 A5 JP 2017521060A5 JP 2016573923 A JP2016573923 A JP 2016573923A JP 2016573923 A JP2016573923 A JP 2016573923A JP 2017521060 A5 JP2017521060 A5 JP 2017521060A5
Authority
JP
Japan
Prior art keywords
rodent
human
endogenous
pdcd1
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016573923A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017521060A (ja
JP6904707B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/036649 external-priority patent/WO2015196051A1/en
Publication of JP2017521060A publication Critical patent/JP2017521060A/ja
Publication of JP2017521060A5 publication Critical patent/JP2017521060A5/ja
Priority to JP2021049567A priority Critical patent/JP7612475B2/ja
Application granted granted Critical
Publication of JP6904707B2 publication Critical patent/JP6904707B2/ja
Priority to JP2023069178A priority patent/JP7720349B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016573923A 2014-06-19 2015-06-19 ヒト化プログラム細胞死１遺伝子を持つ非ヒト動物 Active JP6904707B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2021049567A JP7612475B2 (ja) 2014-06-19 2021-03-24 ヒト化プログラム細胞死１遺伝子を持つ非ヒト動物
JP2023069178A JP7720349B2 (ja) 2014-06-19 2023-04-20 ヒト化プログラム細胞死１遺伝子を持つ非ヒト動物

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201462014181P 2014-06-19 2014-06-19
US62/014,181 2014-06-19
US201462086518P 2014-12-02 2014-12-02
US62/086,518 2014-12-02
US201562138221P 2015-03-25 2015-03-25
US62/138,221 2015-03-25
PCT/US2015/036649 WO2015196051A1 (en) 2014-06-19 2015-06-19 Non-human animals having a humanized programmed cell death 1 gene

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021049567A Division JP7612475B2 (ja) 2014-06-19 2021-03-24 ヒト化プログラム細胞死１遺伝子を持つ非ヒト動物

Publications (3)

Publication Number Publication Date
JP2017521060A JP2017521060A (ja) 2017-08-03
JP2017521060A5 true JP2017521060A5 (https=) 2018-08-02
JP6904707B2 JP6904707B2 (ja) 2021-07-21

Family

ID=53546709

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2016573923A Active JP6904707B2 (ja) 2014-06-19 2015-06-19 ヒト化プログラム細胞死１遺伝子を持つ非ヒト動物
JP2021049567A Active JP7612475B2 (ja) 2014-06-19 2021-03-24 ヒト化プログラム細胞死１遺伝子を持つ非ヒト動物
JP2023069178A Active JP7720349B2 (ja) 2014-06-19 2023-04-20 ヒト化プログラム細胞死１遺伝子を持つ非ヒト動物

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2021049567A Active JP7612475B2 (ja) 2014-06-19 2021-03-24 ヒト化プログラム細胞死１遺伝子を持つ非ヒト動物
JP2023069178A Active JP7720349B2 (ja) 2014-06-19 2023-04-20 ヒト化プログラム細胞死１遺伝子を持つ非ヒト動物

Country Status (24)

Country Link
US (4) US10390522B2 (https=)
EP (2) EP3683238A1 (https=)
JP (3) JP6904707B2 (https=)
KR (2) KR102482295B1 (https=)
CN (2) CN106604635B (https=)
AU (2) AU2015276978B2 (https=)
BR (1) BR112016029650A2 (https=)
CA (1) CA2951278A1 (https=)
CY (1) CY1122940T1 (https=)
DK (1) DK3157956T3 (https=)
ES (1) ES2783424T3 (https=)
HR (1) HRP20200613T1 (https=)
HU (1) HUE048677T2 (https=)
IL (2) IL287519B2 (https=)
LT (1) LT3157956T (https=)
MX (1) MX2016016903A (https=)
PL (1) PL3157956T3 (https=)
PT (1) PT3157956T (https=)
RS (1) RS60097B1 (https=)
RU (1) RU2735958C2 (https=)
SG (2) SG10201811116UA (https=)
SI (1) SI3157956T1 (https=)
SM (1) SMT202000184T1 (https=)
WO (1) WO2015196051A1 (https=)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8307177B2 (en) 2008-09-05 2012-11-06 Commvault Systems, Inc. Systems and methods for management of virtualization data
AU2009333580B2 (en) 2008-12-09 2016-07-07 Genentech, Inc. Anti-PD-L1 antibodies and their use to enhance T-cell function
US9461881B2 (en) 2011-09-30 2016-10-04 Commvault Systems, Inc. Migration of existing computing systems to cloud computing sites or virtual machines
US20140181044A1 (en) 2012-12-21 2014-06-26 Commvault Systems, Inc. Systems and methods to identify uncharacterized and unprotected virtual machines
US9378035B2 (en) 2012-12-28 2016-06-28 Commvault Systems, Inc. Systems and methods for repurposing virtual machines
JP6742903B2 (ja) 2013-05-02 2020-08-19 アナプティスバイオ インコーポレイティッド プログラム死−１（ｐｄ−１）に対する抗体
ES2783424T3 (es) * 2014-06-19 2020-09-17 Regeneron Pharma Animales no humanos que tienen un gen de muerte celular programada 1 humanizado
RU2020122439A (ru) 2014-11-24 2020-09-24 Регенерон Фармасьютикалз, Инк. Не относящиеся к человеку животные, экспрессирующие гуманизированный комплекс cd3
SI3086637T1 (sl) 2014-12-05 2019-04-30 Regeneron Pharmaceuticals, Inc. Nehumane živali s humaniziranim označevalcem diferenciacije gena CD47
HUE052606T2 (hu) * 2014-12-09 2021-05-28 Regeneron Pharma Humanizált differenciációs klaszter 274 génnel rendelkezõ nem humán állatok
US10084873B2 (en) 2015-06-19 2018-09-25 Commvault Systems, Inc. Assignment of data agent proxies for executing virtual-machine secondary copy operations including streaming backup jobs
US9563514B2 (en) 2015-06-19 2017-02-07 Commvault Systems, Inc. Assignment of proxies for virtual-machine secondary copy operations including streaming backup jobs
CN114591433A (zh) 2015-07-13 2022-06-07 西托姆克斯治疗公司 抗pd-1抗体、可活化抗pd-1抗体及其使用方法
SG11201803409UA (en) 2015-11-20 2018-05-30 Regeneron Pharma Non-human animals having a humanized lymphocyte-activation gene 3
MX2018009513A (es) 2016-02-04 2019-01-31 Regeneron Pharma Animales no humanos que tienen un gen angptl8 modificado genéticamente.
CN109068621B (zh) 2016-02-29 2021-07-20 再生元制药公司 具有人源化的tmprss基因的啮齿类动物
TWI755395B (zh) 2016-05-13 2022-02-21 美商再生元醫藥公司 抗-pd-1抗體與輻射治療癌症之組合
WO2017200796A1 (en) * 2016-05-17 2017-11-23 Albert Einstein College Of Medicine, Inc. Engineered pd-1 variants
HUE061619T2 (hu) * 2016-06-03 2023-07-28 Regeneron Pharma Exogén terminális dezoxinukleotid-transzferázt expresszáló rágcsálók
EP3476865B1 (en) 2016-06-28 2023-09-13 Biocytogen Pharmaceuticals (Beijing) Co., Ltd. Method for constructing pd-1 gene-modified humanized animal model and use thereof
US11317611B2 (en) 2016-08-31 2022-05-03 Biocytogen Pharmaceuticals (Beijing) Co., Ltd. Genetically modified non-human animal with human or chimeric PD-L1
CN107815466B (zh) 2016-08-31 2020-03-13 百奥赛图江苏基因生物技术有限公司 人源化基因改造动物模型的制备方法及应用
CA3041684C (en) 2016-11-01 2023-09-26 Anaptysbio, Inc. Antibodies directed against programmed death- 1 (pd-1)
CN107828722B (zh) * 2016-11-04 2021-07-23 北京泰盛生物科技有限公司 特异性表达pd-1的干细胞、其鉴定和分离方法及用途
EP3548515B1 (en) * 2016-12-01 2026-01-21 Regeneron Pharmaceuticals, Inc. Radiolabeled anti-pd-l1 antibodies for immuno-pet imaging
PT3565844T (pt) 2017-01-09 2023-05-02 Tesaro Inc Métodos de tratamento de cancro com anticorpos anti-pd-1
KR20240011262A (ko) 2017-02-21 2024-01-25 리제너론 파아마슈티컬스, 인크. 폐암의 치료를 위한 항-pd-1 항체
US10949308B2 (en) 2017-03-15 2021-03-16 Commvault Systems, Inc. Application aware backup of virtual machines
US10853195B2 (en) 2017-03-31 2020-12-01 Commvault Systems, Inc. Granular restoration of virtual machine application data
CN109136274B (zh) * 2017-06-19 2021-04-23 百奥赛图江苏基因生物技术有限公司 人源化cd40基因改造动物模型的制备方法及应用
CN109136275B (zh) 2017-06-19 2021-03-16 百奥赛图(北京)医药科技股份有限公司 人源化gitr基因改造动物模型的制备方法及应用
CN109136261B (zh) 2017-06-19 2021-03-16 百奥赛图(北京)医药科技股份有限公司 人源化cd28基因改造动物模型的制备方法及应用
CN109280674B (zh) * 2017-07-21 2020-12-01 北京百奥赛图基因生物技术有限公司 一种筛选抗体的非人模式动物的构建方法及其应用
MX394999B (es) * 2017-09-29 2025-03-24 Regeneron Pharma Animales no humanos que comprenden un locus ttr humanizado y metodos de uso
WO2019072241A1 (en) * 2017-10-13 2019-04-18 Beijing Biocytogen Co., Ltd NON-HUMAN ANIMAL GENETICALLY MODIFIED WITH PD-1 HUMAN OR CHIMERIC
CN109666701B (zh) * 2017-10-13 2021-08-24 百奥赛图(北京)医药科技股份有限公司 一种pd-1基因修饰人源化动物模型的构建方法及其应用
IL310006A (en) 2017-11-30 2024-03-01 Regeneron Pharma Non-human animals containing a humanized TRKB locus
KR20250121150A (ko) 2018-03-26 2025-08-11 리제너론 파마슈티칼스 인코포레이티드 치료제를 시험하기 위한 인간화된 설치류
IL278267B2 (en) 2018-07-16 2025-02-01 Regeneron Pharma Non-human animal models of DITRA disease and their uses
CN109266656B (zh) * 2018-10-10 2021-02-19 江苏集萃药康生物科技股份有限公司 一种PD1人源化BALB/c小鼠模型的构建方法及其应用
CN109452229B (zh) * 2018-11-19 2021-10-22 百奥赛图(北京)医药科技股份有限公司 狗源化pd-1基因改造动物模型的制备方法及应用
CN112300265B (zh) * 2019-07-29 2022-09-27 百奥赛图(北京)医药科技股份有限公司 Il33基因人源化的非人动物的构建方法和应用
EP4096396A1 (en) * 2020-01-28 2022-12-07 Regeneron Pharmaceuticals, Inc. Non-human animals comprising a humanized pnpla3 locus and methods of use
US11656951B2 (en) 2020-10-28 2023-05-23 Commvault Systems, Inc. Data loss vulnerability detection
KR20240161968A (ko) 2022-03-16 2024-11-13 다이이찌 산쿄 가부시키가이샤 다중 특이적 분자와 면역 체크 포인트 저해제의 조합
WO2024002259A1 (zh) * 2022-06-29 2024-01-04 百奥赛图(北京)医药科技股份有限公司 一种osm、osmr、il31ra和/或il31基因修饰的非人动物

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2143491C (en) 1994-03-01 2011-02-22 Yasumasa Ishida A novel peptide related to human programmed cell death and dna encoding it
US5670356A (en) 1994-12-12 1997-09-23 Promega Corporation Modified luciferase
US5874304A (en) 1996-01-18 1999-02-23 University Of Florida Research Foundation, Inc. Humanized green fluorescent protein genes and methods
JP2004501631A (ja) 2000-06-28 2004-01-22 ジェネティックス・インスチチュート・リミテッド・ライアビリティ・カンパニー Ｐｄ−ｌ２分子：新規ｐｄ−１リガンドおよびその使用
US6586251B2 (en) * 2000-10-31 2003-07-01 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
ATE540579T1 (de) 2000-11-15 2012-01-15 Ono Pharmaceutical Co Pd-1-defiziente maus und ihre verwendung
US20040033497A1 (en) * 2002-08-13 2004-02-19 Alarcon-Riquelme Marta E. Polymorphisms of PD-1
CN1753912B (zh) * 2002-12-23 2011-11-02 惠氏公司 抗pd-1抗体及其用途
WO2005060739A1 (en) 2003-12-24 2005-07-07 G2 Inflammation Pty Ltd Transgenic non-human mammal comprising a polynucleotide encoding human or humanized c5ar
JP4936899B2 (ja) * 2003-12-24 2012-05-23 ジー２ インフラメイション ピーティーワイ エルティーディー ヒトまたはヒト化Ｃ５ａＲをコードするポリヌクレオチドを含むトランスジェニック非ヒト哺乳動物
AU2005295269B2 (en) 2004-10-19 2010-05-13 Regeneron Pharmaceuticals, Inc. Method for generating an animal homozygous for a genetic modification
RU2494107C2 (ru) * 2005-05-09 2013-09-27 Оно Фармасьютикал Ко., Лтд. Моноклональные антитела человека к белку программируемой смерти 1 (pd-1) и способы лечения рака с использованием анти-pd-1-антител самостоятельно или в комбинации с другими иммунотерапевтическими средствами
EP3214095B1 (en) * 2005-05-12 2019-12-11 ZymoGenetics, Inc. Compositions and methods for modulating immune responses
CN101355965A (zh) 2005-06-08 2009-01-28 达纳－法伯癌症研究院 通过抑制程序性细胞死亡1（pd-1）途经治疗持续性感染和癌症的方法及组合物
AU2009333580B2 (en) 2008-12-09 2016-07-07 Genentech, Inc. Anti-PD-L1 antibodies and their use to enhance T-cell function
RU2425880C2 (ru) * 2009-07-30 2011-08-10 Учреждение Российской академии наук Институт общей генетики им. Н.И. Вавилова РАН Способ получения трансгенных мышей
WO2011020005A1 (en) 2009-08-14 2011-02-17 Regeneron Pharmaceuticals, Inc. miRNA-REGULATED DIFFERENTIATION-DEPENDENT SELF-DELETING CASSETTE
TW201134488A (en) * 2010-03-11 2011-10-16 Ucb Pharma Sa PD-1 antibodies
US8871996B2 (en) * 2010-06-09 2014-10-28 Regeneron Pharmaceuticals, Inc. Mice expressing human voltage-gated sodium channels
SI2770821T1 (en) 2011-10-28 2018-01-31 Regeneron Pharmaceuticals, Inc. Genetically modified major histocompatibility complex of mice
DK3590332T3 (da) 2011-10-28 2022-05-23 Regeneron Pharma Genmodificerede mus, der eksprimerer kimære major histokompatibilitetskompleks (MHC) II-molekyler
LT3424947T (lt) * 2011-10-28 2021-03-10 Regeneron Pharmaceuticals, Inc. Genetiškai modifikuotos t ląstelių receptorių pelės
WO2013063556A1 (en) 2011-10-28 2013-05-02 Regeneron Pharmaceuticals, Inc. Humanized il-6 and il-6 receptor
CA2887706C (en) 2012-11-05 2022-08-02 Regeneron Pharmaceuticals Genetically modified non-human animals and methods of use thereof
KR102714111B1 (ko) 2013-02-20 2024-10-11 리제너론 파아마슈티컬스, 인크. 사람화된 ｔ-세포 보조-수용체를 발현하는 마우스
PL2958937T3 (pl) 2013-02-22 2019-01-31 Regeneron Pharmaceuticals, Inc. Myszy ekspresjonujące humanizowany główny układ zgodności tkankowej
CN105592695B (zh) 2013-09-23 2018-04-10 瑞泽恩制药公司 具有人源化信号调节蛋白基因的非人动物
CA2929846C (en) 2013-11-19 2020-09-15 Regeneron Pharmaceuticals, Inc. Non-human animals having a humanized b-cell activating factor gene
HUE051088T2 (hu) 2014-04-08 2021-03-01 Regeneron Pharma Humanizált FC-gamma receptorokkal rendelkezõ nem humán élõlények
NO2785538T3 (https=) 2014-05-07 2018-08-04
SG10202002187WA (en) 2014-05-19 2020-04-29 Regeneron Pharma Genetically modified non-human animals expressing human epo
ES2783424T3 (es) * 2014-06-19 2020-09-17 Regeneron Pharma Animales no humanos que tienen un gen de muerte celular programada 1 humanizado

Similar Documents

Publication Publication Date Title
JP2017521060A5 (https=)
RU2016149434A (ru) Животные, отличные от человека, имеющие гуманизированный ген 1 запрограммированный гибели клеток
US11178860B2 (en) Humanized C5 animals
JP2018500896A5 (https=)
US11234420B2 (en) Method for constructing PD-1 gene modified humanized animal model and use thereof
HRP20231121T1 (hr) Životinje koje nisu ljudi, koje imaju gen za humanizirani protein koji regulira signale
JP2021094035A5 (https=)
RU2017123754A (ru) Не относящиеся к человеку животные, имеющие гуманизированный ген кластера дифференцировки 274
JP2018533963A5 (https=)
RU2018117944A (ru) Животные, отличные от человека, имеющие гуманизированный ген активации лимфоцитов-3
JP2015523863A5 (https=)
JP2019505216A5 (https=)
AU2018225745A1 (en) Humanized model of kidney and liver disorders
JP2022134132A (ja) ヒトｇｐｃ３ポリペプチドを発現する遺伝子改変非ヒト動物
RU2018130003A (ru) Животные, отличные от человека, имеющие сконструированный ген angptl8
IL319209A (en) Non-human animals containing a humanized ASGR1 locus
JP2021508236A5 (https=)
US20230413791A1 (en) Non-human animals having a humanized clec9a gene
JP7504030B2 (ja) 進行性骨化性線維異形成症のげっ歯類モデル
JP7765403B2 (ja) ヒト化ｃｘｃｌ１３遺伝子を有する非ヒト動物
CN119331910A (zh) 一种gdf8基因修饰的非人动物
WO2023046201A1 (en) Genetically modified non-human animal with human or chimeric genes
US20220192165A1 (en) Non-human animals having a humanized tslp gene, a humanized tslp receptor gene, and/or a humanized il7ra gene
JP5086074B2 (ja) 白髪発症モデル動物、白髪発症モデル動物の樹立方法、白髪発症モデル動物の継代方法、白髪発症の研究方法、白髪発症制御手段のスクリーニング方法、白髪発症制御用組成物
RU2795136C2 (ru) Модель прогрессирующей оссифицирующей фибродисплазии на грызунах